Free from Publisher

Beneficial effects of intermediate dosage of anticoagulation treatment on the prognosis of hospitalized COVID-19 patients: the ETHRA study

G Poulakou, E Dimakakos, A Kollias, KG Kyriakoulis… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: To investigate the efficacy (prognosis, coagulation/inflammation
biomarkers) and safety (bleeding events) of different anticoagulation dosages in COVID-19 …
被引用次数：28 相关文章 Free from Publisher

Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study.

G POULAKOU, E DIMAKAKOS, A KOLLIAS… - In …, 2021 - search.ebscohost.com
Abstract Background/Aim: To investigate the efficacy (prognosis, coagulation/inflammation
biomarkers) and safety (bleeding events) of different anticoagulation dosages in COVID-19 …
[HTML] nih.gov

[HTML][HTML] Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study

G POULAKOU, E DIMAKAKOS, A KOLLIAS… - In Vivo, 2021 - ncbi.nlm.nih.gov
Background/Aim: To investigate the efficacy (prognosis, coagulation/inflammation
biomarkers) and safety (bleeding events) of different anticoagulation dosages in COVID-19 …

Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study.

G Poulakou, E Dimakakos, A Kollias… - In Vivo (Athens …, 2021 - europepmc.org
Results Among 127 admissions, 95 fulfilled the inclusion criteria. Twenty-one events (4
deaths, 17 intubations) were observed. Regression analysis demonstrated significant …

Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study

G Poulakou, E Dimakakos, A Kollias… - In vivo (Athens …, 2021 - pubmed.ncbi.nlm.nih.gov
Background/aim To investigate the efficacy (prognosis, coagulation/inflammation
biomarkers) and safety (bleeding events) of different anticoagulation dosages in COVID-19 …